Overall, we report fundamental differences in the basal composition, biochemical status, and spatial organization of the BcR in the three examined immunogenetic CLL subtypes that correlate with their clinical behavior. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.